Liver-specific LXR inhibition represses reverse cholesterol transport in cholesterol-fed mice
T. Nishida, M. Ayaori, J. Arakawa, Y. Suenaga, K. Shiotani, H. Uto-Kondo, T. Komatsu, K. Nakaya, Y. Endo, M. Sasaki, K. Ikewaki
This study shows that liver-specific LXR inhibition reduces HDL levels and reverse cholesterol transport in cholesterol-fed mice by decreasing LXR-target gene expression.
Atherosclerosis · Oct 1, 2024Peer-reviewedPhysiology